PPS Mobile - Industry News

Home | Industry News | Health Canada Advisories

Delivery of Topical Hemostatic Agents Using Spray Devices - Association with Air/Gas Embolism
- Notice to Hospitals [2010-08-27]
Important Diabetes Information: GlucaGen Hypokit being Recalled in Canada [2010-08-25]
AVASTIN (bevacizumab) - Association with Allergic Reactions - Hoffmann-La Roche Limited
- For Health Professionals [2010-08-23]
- For the Public [2010-08-23]
Adrenalin (epinephrine chloride 1:1000) Intended for Topical Use - Risk of Inadvertent Injection - Erfa Canada Inc.
- For Health Professionals [2010-08-17]
- Notice to Hospitals [2010-08-17]
RELISTOR (methylnaltrexone bromide) Subcutaneous Injection - Association with gastrointestinal perforation - Wyeth Canada
- For Health Professionals [2010-08-03]
- For the Public [2010-08-03]

RotaTeq - Presence of Porcine Circovirus (PCV) DNA - Merck Frosst Canada Ltd.
- For Health Professionals [2010-07-30]
Rotarix - Presence of Porcine Circovirus Type 1 (PCV-1) - GlaxoSmithKline Inc.
- For Health Professionals [2010-07-30]
Unauthorized Health Products Sold by Marigold Natural Pharmacy Ltd. May Pose Health Risks [2010-07-23]
Status of rosiglitazone drugs in Canada (Avandia, Avandamet, and Avandaryl) [2010-07-08]

Proper Dosing of Liquid Vitamin D Supplements in Infants [2010-06-17]
MIRENA (Levonorgestrel-Releasing Intrauterine System) - Potential Risk of Uterine Perforation - Bayer Inc.
- For Health Professionals [2010-06-17]
- For the Public [2010-06-17]
CANCIDAS (caspofungin acetate for injection) - Voluntary Product Recall - Merck Frosst Canada Ltd.
- Notice to Hospitals [2010-06-15]
Baxter Colleague Volumetric Infusion Pumps - Information for Canadian health care facilities related to the recall in the United States
- Notice to Hospitals [2010-06-11]
CIPROFLOXACIN INJECTION - Voluntary Recall
- Notice to Hospitals [2010-06-09]
CHAMPIX (varenicline tartrate) - Changes to the Canadian Product Monograph - Pfizer Canada Inc.
- For Health Professionals [2010-06-03]
- For the Public [2010-06-03]

RISPERDAL CONSTA (risperidone powder for injectable prolonged-release suspension) - Needle Detachments Associated with the Needle Assembly Used for Gluteal Injection - Janssen-Ortho Inc.
- For Health Professionals [2010-05-25]
TYSABRI (natalizumab) - New Safety Information Regarding Progressive Multifocal Leukoencephalopathy (PML) - Biogen Idec Canada Inc.
- For Health Professionals [2010-05-17]
- For the Public [2010-05-17]
Maalox Multi Action (bismuth subsalicylate) - Confusion with Other Maalox Liquid Products - Novartis Consumer Health Canada Inc.
- For Health Professionals [2010-05-17]
- For the Public [2010-05-17]
Cuffed Shiley Tracheostomy Products - Health Canada Endorsed Important Safety Information - Tyco Healthcare Canada
- Notice to Hospitals [2010-05-13]
Updated Information Regarding Recalled Infant and Children Motrin and Tylenol Products [2010-05-10]
Important Information Regarding Rotavirus Vaccines: Rotarix and RotaTeq [2010-05-07]
Exelon Patch (rivastigmine transdermal patch) - Serious Adverse Events Related to Medication Errors/Misuse - Novartis Pharmaceuticals Canada Inc.
- For Health Professionals [2010-05-05]
- For the Public [2010-05-05]

Updated Safety Information for Promethazine Hydrochloride Injection [2010-04-26]
Invirase (saquinavir mesylate) - Association with Dose-Dependent Abnormal Electrical Activity or Conduction in the Heart (Prolongations of QT and PR Intervals) in Healthy Volunteers - Hoffmann-La Roche Limited
- For Health Professionals [2010-04-20]
- For the Public [2010-04-20]
New Expiry Date for Unused Adjuvanted H1N1 Vaccine (Arepanrix) [2010-04-09]
Zeftera (ceftobiprole medocaril) for Injection - Discontinuation of Sale - Janssen-Ortho Inc.
- Notice to Hospitals [2010-04-08]

WinRho SDF (Rho(D) Immune Globulin (Human)) - Association with Intravascular Hemolysis in the Treatment of Immune Thrombocytopenic Purpura (ITP) - Important New Prescribing Information - Cangene Corporation
- Notice to Hospitals
- For the Public

Fentanyl Transdermal Systems - New Changes to the Dose Conversion Guidelines - Janssen-Ortho Inc., Cobalt Pharmaceuticals Inc., Teva Canada Limited, Ranbaxy Pharmaceuticals Canada Inc., ratiopharm inc., Sandoz Canada Inc. and Pharmascience Inc.
- For Health Professionals [2010-03-10]
- Notice to Hospitals [2010-03-10]
- For the Public [2010-03-10]

Poli-Grip - Association of Long-Term, Excessive Use of Zinc-Containing Poli-Grip Products with Myeloneuropathy and Blood Dyscrasias - GlaxoSmithKline
- For Health Professionals [2010-02-23]
- For the Public [2010-02-23]
Nipro GlucoPro Insulin Syringes - Recall - Surgo Surgical Supply
- For Health Professionals [2010-02-19]
- For the Public [2010-02-19]
Accutane (isotretinoin) - Association with Cases of Severe Skin Reactions - Hoffmann-La Roche Limited
- For Health Professionals [2010-02-16]
- For the Public [2010-02-16]
Surgical Mesh - Complications Associated with Transvaginal Implantation of Surgical Mesh for the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse
- Notice to Hospitals [2010-02-05]

OPTIMARK (gadoversetamide injection) - Association with Nephrogenic Systemic Fibrosis (NSF) in Patients with Renal Impairment - Tyco Healthcare (Covidien)
- For Health Professionals [2010-01-12]
- For the Public [2010-01-12]
BiCNU (carmustine for injection) - Type I recall due to Risk of Infection - Bristol-Myers Squibb Canada
- Notice to Hospitals [2010-01-05]